6 questions with dr. alpesh amin on monoclonal antibody therapy - uci health
Published 3 years ago • 1.1K plays • Length 4:58Download video MP4
Download video MP3
Similar videos
-
6:21
dr. alpesh amin, medicine chair – micu and tower medicine floor
-
0:31
what's next - uci health
-
4:51
dr. alpesh amin, dr. jawwad yusuf, and dr. andres leal on wfaa good morning texas
-
1:18
dr. levis discusses the ideal use of quizartinib in flt3-itd aml
-
1:59
tangible benefit for flt3-itd r/r aml on quizartinib
-
1:29
meet our spine surgeons | hansen bow, md
-
3:42
further analysis of quantum-first: the impact of allo-hct combined with quizartinib in flt3-itd aml
-
0:46
what types of questions would you ask your physician?
-
2:29
phase i first-in-human study of alnuctamab in patients with r/r multiple myeloma
-
1:14
phase i study of abbv-383, a bcma×cd3 bispecific antibody, in r/r myeloma
-
2:13
dr erba on the safety of quizartinib by treatment phase and age in flt3-itd–positive aml
-
1:28
dr. levis on the ideal way to use quizartinib to treat aml
-
0:51
the diskcover system "a huge customer satisfier" -alpesh amin, md | stethoscope hygiene experts ep13
-
1:52
doctor answers questions about omicron
-
1:30
uci health — newport beach | christopher zachary, md
-
3:35
identifying risk factors for severe covid-19 in patients with aml, mds and all
-
1:14:36
how to find omics data? (omicslogic bioinformatics for infectious diseases training & research)
-
1:27
diabetes questions: medication and blood glucose control